Clinical Trials
3 trialsNCT00521053 2014-08-25
Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Provectus Pharmaceuticals
Phase 2 Completed
NCT00237354 2008-10-24
PV-10 Chemoablation of Recurrent Breast Carcinoma
Provectus Pharmaceuticals
Phase 1 Completed
NCT00219843 2007-08-23
Intralesional PV-10 Chemoablation of Metastatic Melanoma
Provectus Pharmaceuticals
Phase 1 Completed